User profiles for Elizabeth A Ashley

Elizabeth ASHLEY

LOMWRU
Verified email at tropmedres.ac
Cited by 26095

[HTML][HTML] Spread of Artemisinin Resistance in Plasmodium falciparum Malaria

EA Ashley, M Dhorda, RM Fairhurst… - … England Journal of …, 2014 - Mass Medical Soc
Background Artemisinin resistance in Plasmodium falciparum has emerged in Southeast Asia
and now poses a threat to the control and elimination of malaria. Mapping the geographic …

[HTML][HTML] Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study

AP Phyo, S Nkhoma, K Stepniewska, EA Ashley, S Nair… - The Lancet, 2012 - thelancet.com
Background Artemisinin-resistant falciparum malaria has arisen in western Cambodia. A
concerted international effort is underway to contain artemisinin-resistant Plasmodium …

[HTML][HTML] Genetic architecture of artemisinin-resistant Plasmodium falciparum

O Miotto, R Amato, EA Ashley, B MacInnis… - Nature …, 2015 - nature.com
We report a large multicenter genome-wide association study of Plasmodium falciparum
resistance to artemisinin, the frontline antimalarial drug. Across 15 locations in Southeast Asia, …

Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance

S Mok, EA Ashley, PE Ferreira, L Zhu, Z Lin, T Yeo… - Science, 2015 - science.org
Artemisinin resistance in Plasmodium falciparum threatens global efforts to control and
eliminate malaria. Polymorphisms in the kelch domain–carrying protein K13 are associated with …

[HTML][HTML] Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker

…, PY Cheah, S Pukrittayakamee, EA Ashley… - The Lancet infectious …, 2015 - thelancet.com
Background Emergence of artemisinin resistance in southeast Asia poses a serious threat
to the global control of Plasmodium falciparum malaria. Discovery of the K13 marker has …

[HTML][HTML] Antimicrobial resistance in Africa: a systematic review

BT Tadesse, EA Ashley, S Ongarello, J Havumaki… - BMC infectious …, 2017 - Springer
Background Antimicrobial resistance (AMR) is widely acknowledged as a global problem,
yet in many parts of the world its magnitude is still not well understood. This review, using a …

[HTML][HTML] Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective …

…, M Dhorda, K Chotivanich, EA Ashley… - The Lancet infectious …, 2019 - thelancet.com
Background The emergence and spread of resistance in Plasmodium falciparum malaria to
artemisinin combination therapies in the Greater Mekong subregion poses a major threat to …

[HTML][HTML] Primaquine: the risks and the benefits

EA Ashley, J Recht, NJ White - Malaria journal, 2014 - Springer
Primaquine is the only generally available anti-malarial that prevents relapse in vivax and
ovale malaria, and the only potent gametocytocide in falciparum malaria. Primaquine …

[HTML][HTML] Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment

VI Carrara, J Zwang, EA Ashley, RN Price… - PloS one, 2009 - journals.plos.org
Background Artemisinin combination treatments (ACT) are recommended as first line treatment
for falciparum malaria throughout the malaria affected world. We reviewed the efficacy of …

[HTML][HTML] Drugs in development for malaria

EA Ashley, AP Phyo - Drugs, 2018 - Springer
The last two decades have seen a surge in antimalarial drug development with product
development partnerships taking a leading role. Resistance of Plasmodium falciparum to the …